在肝移植受体中，预防丙肝病毒复发：过继免疫治疗的作用吗？
Preventing hepatitis C virus recurrence in liver transplant recipients: A role for adoptive immunotherapy?
目的观察白细胞介素4（IL-4）局部过继免疫治疗小鼠膀胱癌的效应并探讨其相关机制。
Objective To investigate the effects and the mechanisms of local adoptive immunotherapy of murine bladder cancer with interleukin-4 (IL-4).
结论：CIK细胞在体外扩增能力强，对肿瘤细胞的杀伤活性高，有望成为新一代抗肿瘤过继免疫细胞制剂而应用于临床。
CONCLUSION: CIK cells have strong proliferative ability and higher cytotoxicity to tumor cells in vitro, which could be used as a potential anti-tumor adoptive immunotherapy in clinic.
用于过继免疫治疗的活性细胞必须具有较强的细胞活性和增殖力，CIK细胞被认为是新一代抗肿瘤过继细胞免疫治疗的首选方案。
The cell used in adoptive immunotherapy must have strong cytotoxic and proliferative ability, so CIK cell is thought of the new generation anti-tumor adoptive immunity treatment.
用于过继免疫治疗的活性细胞必须具有较强的细胞活性和增殖力，CIK细胞被认为是新一代抗肿瘤过继细胞免疫治疗的首选方案。
The cell used in adoptive immunotherapy must have strong cytotoxic and proliferative ability, so CIK cell is thought of the new generation anti-tumor adoptive immunity treatment.
应用推荐